| 2024 Active Requests for Applications (RFA's) | |
| RFA No. and Title | Status - Expiration |
|---|---|
| CA24-005 Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) | ACTIVE - OCT 14, 2023 |
| 2024 Active Trans-NIH Requests for Applications (RFA's) | |
| RFA No. and Title | Status - Expiration |
|---|---|
| HD24-011 HEAL Initiative: HEAL KIDS (Knowledge, Innovation and Discovery Studies) Pain: Acute Pain Clinical Trials Program (U01 Clinical Trial Required) | ACTIVE - NOV 21, 2023 |
| 2023 Active Requests for Applications (RFA's) | |
| RFA No. and Title | Status - Expiration |
|---|---|
| CA23-036 Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed) | ACTIVE - NOV 16, 2023 |
| CA23-033 Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) | ACTIVE - DEC 16, 2023 |
| CA23-025 Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required) | EXPIRED - JUL 01, 2023 |
| CA23-015 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) | ACTIVE - NOV 18, 2023 |
| CA23-007 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) | EXPIRED - SEP 02, 2023 |
| 2023 Active Trans-NIH Requests for Applications (RFA's) | |
| RFA No. and Title | Status - Expiration |
|---|---|
| OD23-021 Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required) | ACTIVE - DEC 07, 2023 |
| 2023 Active Program Announcements (PAs) | |
| PA No. and Title | Status - Expiration |
|---|---|
| PAR23-051 Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed) | ACTIVE - OCT 24, 2025 |
| 2023 Active Trans-NIH Program Announcements (PAs) | |
| PA No. and Title | Status - Expiration |
|---|---|
| PAR23-203 Limited Competition: Collaborative Partnership to Advance Global Health Research (U01 Clinical Trial Not Allowed) | EXPIRED - SEP 02, 2023 |
| PAR23-182 Accelerating Behavioral and Social Science through Ontology Development and Use: Research Network Projects (U01 Clinical Trial Not Allowed) | ACTIVE - OCT 04, 2023 |
| 2022 Active Program Announcements (PAs) | |
| PA No. and Title | Status - Expiration |
|---|---|
| PAR22-234 The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) | ACTIVE - JUN 21, 2025 |
| PAR22-162 Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) | ACTIVE - MAR 01, 2025 |
| PAR22-161 Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) | ACTIVE - MAR 01, 2025 |
| PAR22-147 Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) | ACTIVE - NOV 02, 2024 |
| PAR22-049 Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) | ACTIVE - SEP 14, 2024 |
| 2022 Active Trans-NIH Program Announcements (PAs) | |
| PA No. and Title | Status - Expiration |
|---|---|
| PAR22-123 Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) | ACTIVE - JAN 08, 2025 |
| 2021 Active Program Announcements (PAs) | |
| PA No. and Title | Status - Expiration |
|---|---|
| PAR21-348 The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional) | ACTIVE - DEC 16, 2023 |
| PAR21-334 Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) | ACTIVE - JUN 12, 2024 |
| PAR21-330 Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) | ACTIVE - OCT 12, 2024 |
| 2021 Active Trans-NIH Program Announcements (PAs) | |
| PA No. and Title | Status - Expiration |
|---|---|
| PAR21-343 Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) | ACTIVE - APR 19, 2024 |